PHASE II-IV CLINICAL TRIAL MANAGEMENT

Novum manages clinical endpoint studies that require large patient populations in multiple disease states, treated in an outpatient setting. With a nationwide network of more than 2,000 investigator sites, we ensure that all selected sites meet the requirements of each study and Novum’s high standards.